Takeda Powers U.S. Biopharma Leadership and Innovation in Massachusetts

Takeda’s long-standing presence in Massachusetts shows how a supportive local ecosystem drives biopharma growth, translating to economic progress nationwide.

Takeda is central to Massachusetts’ world-leading life sciences ecosystem through its global innovation hub, and world-class manufacturing sites and long-standing commitment to strengthening local communities. As the Commonwealth’s largest life sciences employer, TakedaThe company’s deep roots, and transformative investments, bolstered by a premier workforce and strong public-private partnerships are redefining how Massachusetts – and the United States – discover and deliver, continue to redefine the commonwealth’s, and America’s, discovery and production of new medicines.

To maintaining America’s leadership in biopharma innovation, Takeda is committing $30 billion of new investment in U.S. manufacturing and R&D through the end of the decade.

“The biggest part of what makes this place special is the collaboration between private [sector], government and also the community,” explained Rhonda Pacheco, President, U.S. Business Unit and U.S. Country Head, Takeda.

Takeda is also empowering the next generation of innovators and leaders by supporting programs like MassNextGen. This initiative, created by the Massachusetts Life Sciences Center, continues strengthens the legacy of life sciences innovation by providing support and resources to underrepresented entrepreneurs.

This unique ecosystem is fueling the discovery of patient-centered medicines that make an impact for patients around the globe. Leveraging advanced automation, robotics and AI, Takeda is working to fundamentally change how we approach discovery and research to bring new, next-generation treatments to patients faster.